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Antiphospholipid antibodies and subsequent thrombo-occlusive
events in patients with ischemic stroke
The APASS Investigators. JAMA 2004;291:576-84.
Conclusions: In patients with ischemic stroke, antiphospholipid anti-
bodies (lupus anticoagulant [LA] or anticardiolipin antibody [aCL]) do not
predict an increased risk for another thromboembolic or vascular occlusive
event over 2 years, nor do they predict a differential response to warfarin or
aspirin therapy.
Summary: This is a prospective study derived from participants in the
warfarin versus aspirin recurrent stroke study (WARSS). The current study,
the antiphospholipid antibodies and stroke study (APASS), tested hypoth-
eses specified prior to initiation of the WARSS. The goal was to evaluate the
effect of baseline antiphospholipid antibody positivity on late thrombo-
occlusive events in patients with ischemic stroke. The main outcome mea-
sure was a 2-year rate of the composite end point of death from any cause,
ischemic stroke, transient ischemic attack, myocardial infarction, deep ve-
nous thrombosis, pulmonary embolism, and other systemic thrombo-occlu-
sive events. Analysis was done with respect to both aCL and LA levels.
Therewere1,770APASSpatients.Ofthese,720(41%)wereantiphospho-
lipid antibody positive and 1,050 (59%) were negative. Positive antiphos-
pholipid antibody status did not confer increased risk of thrombo-occlusive
events during follow-up. This was true for patients treated with warfarin
(relative risk [RR], 0.99; 95% confidence interval [CI], 0.75-1.31; P .94)
or aspirin (RR, 0.94; 95% CI, 0.70-1.28; P  .71). The overall composite
end-point event rate in antiphospholipid antibody–positive patients was
22.2%; it was 21.8% among negative patients. Patients who were positive at
baseline for both LA and aCL tended to have a higher event rate (31.7%)
than did patients who tested negative for both LA and aCL (24.0%), (RR,
1.36; 95% CI, 0.97-1.92; P .07). There were no specific LA tests, or aCL
isotopes or titers, that conferred increased risk of thrombo-occlusive events.
Comment: Antiphospholipid antibodies are linked to an immune-
mediated coagulopathy. The data here indicate no role for antiphospholipid
antibodies in predicting subsequent vascular risk in patients with ischemic
stroke or in predicting response to aspirin or warfarin therapy. By inference,
the true role of antiphospholipid antibodies in patients with peripheral
vascular disease probably still remains to be defined.
Inhibition of experimental abdominal aortic aneurysm in the rat by use
of decoy oligodeoxynucleotides suppressing activity of nuclear factor
kb and ets transcription factors
Nakashima H, Aokin M, Miyake T, et al. Circulation 2004;109:132-8.
Conclusion: The use of a chimeric decoy active against nf-kb and ets
transcription factors inhibits progression of aneurysmal dilatation in a rat
model of abdominal aortic aneurysm (AAA).
Summary: Matrix metalloproteinases (MMPs) lead to destruction of
elastin and may play a role in aneurysm development and rupture. Transcrip-
tion factor nuclear factor (nf)-kb regulates the transcription of MMP 1, 2, 3,
and 9. The ets-1 family of transcription factors activates the transcription of
genes coding MMP 1, 3, and 9. The authors developed a chimeric decoy
oligodeoxynucleotide (ODN) to inhibit both nf-kb and ets transcription
factors. The goal was to decrease aneurysmal degeneration in a rat model
through delivery of ODN and subsequent inhibition of MMP expression.
AAAs were induced in rats by transient aortic profusion with elastase.
Transfection of decoy ODN was performed by wrapping a delivery sheet
containing ODN around the aorta. At 7 days, using a gel-mobility shift assay,
both ets and nf-kb binding activities were inhibited by the decoy. Animals
treated with the chimeric decoy ODN had significantly less progression of
AAA enlargement at 4 weeks than control animals. This was accompanied by
a reduction of MMP expression. Scrambled decoy ODN had no effect.
Comment: These data suggest a potentially important role in aneu-
rysm development for transcription factors nuclear factor (nf)-kb and ets-1.
The chimeric decoy is able to bind to free nf-kb and ets and thereby prevent
activation of genes dependent upon these transcription factors. This is truly
exciting research targeting inhibition of degenerative processes at the ge-
netic level.
Poor control of risk factors for vascular disease among adults with
previously diagnosed diabetes
Saydah SH, Fradkin J, Cowie CC. JAMA 2004;291:335-42.
Conclusion: Only 7.3% of adults with diabetes meet recommended
goals for hemoglobin (HbA1c) levels, blood pressure, and total cholesterol.
Summary: The American Diabetes Association (ADA) has standards of
medical care for individuals with diabetes. The aim is to reduce vascular
complications of diabetes. The ADA goal for glycemic control is HbA1c
levels 7%. The goal for blood pressure control is a systolic pressure 130
mm Hg and a diastolic pressure 80 mm Hg. The national cholesterol
education program adult treatment panel sets a goal of a total cholesterol
level of 200 mg/dL.
The authors analyzed adultsage 20 years with known and previously
diagnosed diabetes who had participated in 2 National Health and Nutrition
Examination Surveys (NHANES). The first survey was conducted between
1988 and 1994 and the second from 1999 to 2000. In the latter survey, only
37% of participants achieved a target goal of HbA1c level7%. Only 35.8%
of participants achieved a target of a systolic blood pressure 130 mm Hg
and a diastolic pressure80 mm Hg. With respect to hemoglobin A1c levels
and blood pressure control, there was no improvement from the 1988-1994
survey to the 1999-2000 survey. In the first NHANES survey 66.1% had a
total cholesterol level 200 mg/dL, while in the second NHANES survey
51.8% had a total cholesterol200 mg/dL, (P .001). Overall, only 7.3%
(95% confidence interval, 2.8-11.9) of adults in the second NHANES survey
met recommended goals of HbA1c, blood pressure, and total cholesterol.
Comment: The study indicates that, despite widespread publicity
regarding the importance of glycemic, lipid, and blood pressure control in
patients with diabetes, the US health care system has not worked well to
improve glycemic and blood pressure control in people with diabetes. While
lipid levels have improved, they are still unacceptable. Clearly, further public
health efforts are urgently needed to control risk factors for vascular disease
among people with diabetes.
Does supervised exercise offer adjuvant benefit over exercise advice
alone for the treatment of intermittent claudication? A randomized
trial
Cheetham BR; Burgess L; Ellis N; et al. Eur J Vasc Endovasc Surg 2004;
27:17-23.
Conclusion: A weekly supervised exercise class for 6 months provides
greater improvement in patient symptoms, walking distance, and quality of
life than does written and verbal exercise advice alone.
Summary: The study consisted of 59 patients with intermittent clau-
dication. The patients were randomized to receive just advice to exercise
(n  30), or to receive advice to exercise along with a once-a-week 45-
minute supervised exercise/motivation class (n  29). The patients were
evaluated at baseline and at 6-month follow-up. Evaluation included a
short-form quality of life questionnaire (SF-36), the Charing Cross symp-
tom-specific claudication questionnaire (CCCQ), and treadmill walking
distance at 3.5km/h with a 12% grade.
The mean age of the patients was 68 years. At 6-month follow-up, the
supervised exercise group improved treadmill walking by 129%. The advice-
alone group improved treadmill walking by 69% (P  .001). Improvement
was maintained at 9- and 12- month assessments. There were no significant
differences between the groups with regard to follow-up SF 36 scores
compared with baseline. By 9 months the advice-only group’s CCCQ score
improved 16% from baseline while the supervised-exercise group had a 43%
improvement over baseline (P  .05). At 6 months, the supervised-exercise
group reported a higher frequency of 30-minute walks compared with the
advice-only group.
Comment: The data indicate the power of continual reinforcement in
a structured program to maximize the beneficial effects of exercise therapy in
patients with intermittent claudication. Patients who undergo interventional
or operative treatment of claudication are rarely normalized. It would be
interesting to see if supervised exercise programs in patients who undergo
angioplasty or surgery for claudication would also improve overall quality of
life and walking distance over that achieved with intervention alone.
Transient Ischemic Attacks Before Ischemic Stroke: Preconditioning
the Human Brain? A Multicenter Magnetic Resonance Imaging Study
Wegener S, Gottchalk B, Jobanobic B, et al. Stroke 2004;35:616-21.
Conclusion: Stroke patients with and without prodromal transient
ischemic attacks (TIAs) have similar profusion lesions, but patients with
prodromal transient ischemic attacks have smaller final infarct sizes, suggest-
ing a neuroprotective effect of TIAs in patients with subsequent stroke.
Summary: The authors studied 65 patients with first-ever ischemic
strokes who were admitted to 4 university hospitals in Germany. Patients
were examined with diffusion and profusion weighted magnetic resonance
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imaging within 12 hours of symptoms. Clinical and epidemiologic data,
lesion volumes, apparent diffusion coefficient maps, profusion maps, and
cerebral blood flow and cerebral blood flow values were compared in
patients without and with prodromal TIAs.
Among the 65 patients with territorial strokes, 16 had prodromal TIAs.
In the patients with TIAs prior to stroke, the TIA occurred within 4 weeks of
the stroke in 10 patients and more than 4 weeks from the stroke in 6 patients.
Final infarct size was significantly less in stroke patients with prodromal TIAs
than in those without TIAs (P  .014). Differences in infarct volume were
even more pronounced between patients without prodromal TIAs and
patients whose TIAs occurred fewer than 4 weeks from the onset of stroke
(P  .002). Patients with prodromal TIAs had milder clinical deficits than
those without TIAs. Multiple regression analysis indicated that the only
analyzed parameter predictive of small final infarct size was prodromal TIAs.
Comment: This study argues for an intrinsic neuroprotective effect of
TIAs in patients with subsequent stroke that is independent of changes in
blood flow and collateral development. The mechanism of this neuropro-
tection is unknown, but the data suggest a new line of research with regard
to inducing tolerance of neural tissues to ischemia.
Thrombogenesis and endothelial damage/dysfunction in peripheral
artery disease: relationship to ethnicity and disease severity
Mankin AJ, Chung NAY, Silverman SH, Lip GYH. Thromb Res 2003;11:
221-6.
Conclusions: Peripheral arterial disease (PAD) is associated with a
prothrombotic state characterized by increased levels of markers of endo-
thelial function/damage, platelet activation, and thrombosis, which do not
differ with respect to ethnicity. The only prothrombotic marker related to
severity of PAD is plasma fibrinogen levels.
Summary: The authors investigated markers of platelet activation and
endothelial function in 234 patients (80% white, 7% Indo-Asian, 13%
Afro-Caribbean) with PAD (ankle-brachial index 0.8) and 50 control
patients without evidence of PAD. Levels of soluble P-selectin (a marker of
platelet activation), vonWillebrand factor (an index of endothelial function/
damage), tissue factor, and fibrinogen were correlated with disease severity
and ethnicity.
All of the markers studied were higher in patients with PAD versus
controls without PAD (P .05). There was no difference in the level of any
of the markers among the ethnic groups studied. Patients with ischemic rest
pain had higher levels of plasma fibrinogen (P .001). No other prothrom-
botic markers were higher in the rest pain group. There was an inverse
correlation between fibrinogen and the ankle-brachial index (Speerman, r
-0.178; P  .009).
Comment: A frequent end point of atherosclerosis is thrombosis. Data
from this study suggest that patients with atherosclerosis may be predisposed
to thrombosis through a prothrombotic state associated with PAD. The
clinical relevance of a generalized prothrombotic state in patients with
atherosclerosis is, however, unclear, as disease severity appeared to correlate
only with fibrinogen levels.
A cross-sectional study evaluating post-thrombotic syndrome in chil-
dren
Kuhles S, Koloshuk B, Marzinotto V, et al. Thromb Res 2003;111:227-33.
Conclusion: Post-thrombotic syndrome (PTS) is a clinically significant
disease in children with previous upper extremity and lower extremity deep
venous thrombosis (DVT).
Summary: The authors performed a cross-sectional study in 151
pediatric patients with objectively confirmed upper and/or lower extremity
DVT. All subjects were assessed by using a standardized PTS score to
determine the clinical characteristics, incidence, and predictors of PTS in
children. Severity of PTS was classified as absent, mild, moderate, or severe
according to the scoring system.
All patients’ DVT was diagnosed by objective testing. Fifty-three (35%)
of children had upper extremity DVT; 91 (59%) had lower extremity DVT.
Anticoagulant therapy was used in 95% with a median duration of 3 months.
Age was the only demographic that differed between children who devel-
oped PTS after DVT and those who did not develop PTS after DVT: the
PTS children were slightly older than children with DVT and no PTS.
PTS was present in 63% of children overall. There was no difference in
the children with and without PTS with respect to upper extremity or lower
extremity DVT. According to the severity scoring system, PTS was classified
as mild in 83%, moderate in 17%. No patients had severe PTS. The most
common objective clinical presentation was increased limb circumference
(71%) and the presence of a visible collateral circulation (53%). The most
common clinical complaint was swelling (43%).
Forty-one percent of children had complete resolution of DVT. Chil-
dren with no resolution or extension of DVT, as assessed by objective
testing, were 4 times more likely to have PTS than children with DVT
resolution. For every additional vessel involved in the initial DVT, the
likelihood for a higher PTS score increased by a factor of 2.1. For every year
following the initial DVT, the likelihood for having a higher PTS score
increased by a factor of 1.2.
Comment: This is one of the first articles detailing the risk and
magnitude of the late effects of DVT in children and indicates the post-
thrombotic syndrome is a clinically detectable disease in children but does
not apparently lead to all that much disability. The fact there was no
difference in the frequency and magnitude of PTS between children with
upper and lower extremity DVT may reflect that the etiologies of upper and
lower extremity DVT in children are both generally catheter related. This is
in contrast to adults, where upper extremity DVT is largely catheter related
and of little late clinical significance, whereas lower extremity DVT is not
catheter related and often has late clinical significance.
Stent-graft repair of penetrating atherosclerotic ulcers in the descend-
ing thoracic aorta: mid-term results
Demers P, Claire DC, Mitchell RS, et al. Annals Thoracic Surgery 2004;77:
81-6.
Conclusions: Stent-graft repair of penetrating atherosclerotic ulcers in
the descending thoracic aorta has a high initial success rate. However,
freedom from treatment failure is only 65% at 5 years. Both female sex and
larger aortic diameters were risk factors for treatment failure.
Summary: Between 1993 and 2000, endovascular repair of penetrat-
ing atherosclerotic ulcers (PAUs), with both custom fabricated and com-
mercial stent grafts, was performed in 26 patients. The mean age was 70
years, and 6 patients had evidence of rupture. Fourteen patients (54%) were
not considered candidates for open surgical repair. Follow-up was complete
in all patients and averaged 51 months, with a maximum 114 months.
Three of the 26 patients died within 30 days and 2 had an early type I
endoleak. The primary success rate for placement of a descending aortic stent
graft was 92%. Survival at 1, 3, and 5 years was 85%, 76%, and 70%. Freedom
from treatment failure was 81%, 71%, and 65% at 1, 3, and 5 years,
respectively. Multivariable analysis indicated predictors of treatment failure
were increasing aortic diameter (hazard ratio: 1.1 [per millimeter above the
mean value]; P  .01) and female sex (hazard ratio 5.5; P  .09).
Comment: As with endovascular repair of abdominal aortic aneurysms,
endovascular repair of the descending thoracic aorta appears to be a techni-
cally possible, but not curative, treatment. The data suggests the devices
currently available for the thoracic aorta are, in terms of effectiveness and
clinical durability, still inferior to those available for treatment of infrarenal
abdominal aortic aneurysms.
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